NeuroXtech Achieves Breakthrough in Second Clinical Trial of Fully Implantable, Wireless, and Functional BCI System

On April 23, The Paper learned that NeuroXess announced a critical breakthrough in its second clinical trial following the completion of the first fully self-developed, fully implantable, fully wireless, and full-function ("three-all") brain-computer interface clinical implant by the end of 2025. Through the deep integration of 50-millisecond full-link ultra-low latency and brain-computer interface-driven functional electrical stimulation technology (BCI-FES), a 29-year-old art teacher with high-level paraplegia was able to achieve independent eating and painting creation.

Interface News learned that the BCI-FES used in this clinical trial for the first time deeply integrates the "Triple-All" system with Functional Electrical Stimulation (FES) technology, creating a complete closed-loop of "Thought-Decoding-Stimulation-Movement": Precise acquisition and real-time analysis of motor intentions through cortical electrodes bypasses the damaged spinal cord, accurately stimulating peripheral muscles to achieve natural and coordinated finger movements. Clinical validation showed that one month post-surgery, patients had achieved precise active grasp of the affected hand through thought control, autonomously completing high-precision tasks such as writing and drawing, truly returning control to the patient's own limbs.